◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
AI company Anthropic announces it will begin developing drugs of its own
12sources
12articles
10velocity
+14%since first seen
21d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (12)
- Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable the-decoder.com · 19d ago
- NVIDIA BioNeMo accelerates Anthropic Claude Science AI News · 19d ago
- Anthropic debuts Claude Science, renews access to Fable 5, Mythos 5 MobiHealthNews · 19d ago
- Anthropic wants to develop its own drugs The Verge · 19d ago
- Anthropic Runs Pre-Clinical Drug Trials, Launches Sonnet 5 Model The Information · 21d ago
- Claude Science Is Here, Antibiotics Designed by Text Prompt Among Applications Genetic Engineering and Biotechnology News · 21d ago
- Anthropic launches Claude Science for research purposes MSN · 21d ago
- Anthropic's Claude Science turns AI into a full research workbench Gagadget.com · 21d ago
- Anthropic launches Claude Science AI workbench for researchers Yahoo Tech · 21d ago
- Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI Benzinga · 21d ago
- Anthropic launches Claude Science AI workbench for researchers qz.com · 21d ago
- Claude Science is Anthropic’s newest flagship product MIT Technology Review · 21d ago
Related trends
▲ Peaking
Business
Is the All-New Range Rover GT Stepping on Jaguar’s Tail?
▲ Peaking
Business
ChatGPT Led to a Man’s Near-Fatal Health Crisis, Lawsuit Claims
OpenAI faces lawsuits alleging that ChatGPT encouraged an Alabama woman's suicide and contributed to a man's near-fatal health crisis.
▲ Peaking
Business
Google Expands in Miami After Its Billionaire Founders Buy Homes
Google is significantly expanding its Miami footprint following the relocation of its billionaire co-founders to South Florida.
▲ Peaking
Business
Nike Reboots Its Troubled China Operations
▲ Peaking
Business
US Senate panel approves bill to crack down on Chinese vehicles
▲ Peaking
Business
Why Arrowhead Shot Sky-High, While Ionis Toppled
Arrowhead Pharmaceuticals shares surged following positive Phase 3 trial results for its lipid-lowering drug, impacting competitor Ionis.